Predictive Accuracy of HeartMate 3 Risk Score After the Heart Transplant Allocation Change

Justin D. Vincent, Alyssa Ramsay, David S. Lambert, Elena Deych, Ana María Pico, Erin Coglianese, Justin M. Vader, Bin Q. Yang

Research output: Contribution to journalArticlepeer-review

Abstract

The HeartMate 3 risk score (HM3RS) was developed from the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) clinical trial to predict 1 and 2 year mortality after left ventricular assist device implantation. However, it has not been validated in a real-world population, especially after the heart transplant allocation system change on October 18, 2018. In this multicenter retrospective analysis, we found that HM3RS did not predict 1 and 2 year outcomes in the contemporary era, highlighting the need to revise this risk prediction tool in the real-world setting.

Original languageEnglish
Article number10.1097/MAT.0000000000002343
JournalASAIO Journal
DOIs
StateAccepted/In press - 2024

Keywords

  • Heartmate 3 risk score
  • left ventricular assist device
  • MOMENTUM 3
  • UNOS heart transplant allocation system

Fingerprint

Dive into the research topics of 'Predictive Accuracy of HeartMate 3 Risk Score After the Heart Transplant Allocation Change'. Together they form a unique fingerprint.

Cite this